Board Meeting Details
The Board of Directors meeting was held on July 29, 2026, commencing at 17:00 hours IST and concluding at 19:30 hours IST.
Financial Results Approval
The Board approved the Unaudited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2026.
Standalone Financial Performance (₹ in millions)
Income Statement:
- Revenue From Operations: Q1 FY27: ₹9,577.28 (Q4 FY26: ₹7,233.31; Q1 FY26: ₹6,719.09; FY26: ₹28,085.32)
- Other Income: Q1 FY27: ₹34.27 (Q4 FY26: ₹26.10; Q1 FY26: ₹55.06; FY26: ₹151.94)
- Total Income: Q1 FY27: ₹9,611.55 (Q4 FY26: ₹7,259.41; Q1 FY26: ₹6,774.15; FY26: ₹28,237.26)
Expenses:
- Cost of raw materials consumed: ₹6,175.36
- Purchases of stock-in-trade: ₹102.24
- Changes in inventories: (₹210.24)
- Power and fuel: ₹765.14
- Employee benefits expenses: ₹374.44
- Finance cost: ₹41.98
- Depreciation and amortisation: ₹213.28
- Other expenses: ₹1,300.43
- Total Expenses: ₹8,762.63
Profitability:
- Profit before tax: ₹848.92 (Q4 FY26: ₹323.87; Q1 FY26: ₹177.53; FY26: ₹925.82)
- Tax Expense: ₹215.97 (Current: ₹0; Deferred: ₹215.97)
- Profit after tax: ₹632.95 (Q4 FY26: ₹225.20; Q1 FY26: ₹229.70; FY26: ₹792.58)
- Other Comprehensive Income: ₹3.76
- Total comprehensive income: ₹636.71
Per Share Data:
- Basic EPS: ₹2.28 (Q4 FY26: ₹0.81; Q1 FY26: ₹0.83; FY26: ₹2.86)
- Diluted EPS: ₹2.28 (Q4 FY26: ₹0.81; Q1 FY26: ₹0.82; FY26: ₹2.86)
Consolidated Financial Performance (₹ in millions)
Income Statement:
- Revenue From Operations: Q1 FY27: ₹9,683.38 (Q4 FY26: ₹7,353.10; Q1 FY26: ₹6,929.30)
- Other Income: Q1 FY27: ₹34.39 (Q4 FY26: ₹27.14; Q1 FY26: ₹55.07)
- Total Income: Q1 FY27: ₹9,717.77 (Q4 FY26: ₹7,380.24; Q1 FY26: ₹6,984.37)
Profitability:
- Profit before tax: ₹917.57 (Q4 FY26: ₹324.72; Q1 FY26: ₹141.90)
- Tax Expense: ₹240.41 (Current: ₹46.31; Deferred: ₹194.10)
- Profit after tax: ₹677.16 (Q4 FY26: ₹215.51; Q1 FY26: ₹213.91)
- Other Comprehensive Income: ₹3.76
- Total comprehensive income: ₹680.92
Per Share Data:
- Basic EPS: ₹2.44 (Q4 FY26: ₹0.77; Q1 FY26: ₹0.77)
- Diluted EPS: ₹2.44 (Q4 FY26: ₹0.77; Q1 FY26: ₹0.76)
Capital Structure
- Paid-up share capital: ₹554.42 million (Face value ₹2 per share)
- Number of equity shares: 277,211,567 (Increased from 277,147,873 in previous quarter)
Significant Accounting Notes
Tax Regime Change:
The company exercised option under section 200 of Income-tax Act, 2025 (corresponding to section 115BAA of Income-tax Act, 1961) to compute income tax at 25.17% effective from current financial year. This represents a change from:
- Q1 FY25: New tax regime under Section 115BAA
- Q4 FY26: Old tax regime at 34.94% (reverted due to Union Budget 2026-27 amendments)
- The tax expense for Q1 FY27 is not comparable with previous periods due to tax regime changes, utilization of brought forward losses, and MAT credit recognition in FY26.
Labour Codes Impact:
Recognized ₹38.02 million as Statutory Impact of New Labour Codes towards additional gratuity liability and compensated absences for FY26, classified as past service cost.
ESOP Allotment:
Allotted 63,694 equity shares of face value ₹2 each on April 3, 2026, to option grantees, increasing paid-up capital from ₹554.30 million to ₹554.42 million.
Subsidiaries and Associates
Entities included in consolidation:
- Subsidiaries: Cellbion Lifesciences Private Limited, Laxmi Organic Industries (Europe) B.V., Viva Lifesciences Private Limited, M/s Saideep Traders, Laxmi Speciality Chemicals (Shanghai) Co. Limited, Laxmi Italy SRL
- Associates: Cleanwin Energy One LLP, Radiance MH Sunrise Seven Private Limited
Audit Scope Limitations:
- Three subsidiaries with total revenues of ₹67.09 million and net profit of ₹5.85 million were reviewed by other auditors
- Two subsidiaries with nil revenue and loss of ₹4.72 million were not reviewed by their auditors
- Two associates with nil profit were not reviewed by their auditors